![](/img/cover-not-exists.png)
A phase I/II trial of Z-Dex (oral idarubicin and dexamethasone), an oral equivalent of VAD, as initial therapy at diagnosis or progression in multiple myeloma
G. Cook, R. A. Sharp, P. Tansey, I. M. FranklinVolume:
93
Year:
1996
Language:
english
Pages:
4
DOI:
10.1046/j.1365-2141.1996.d01-1715.x
File:
PDF, 245 KB
english, 1996